While there was not much new among the solutions offered at a U.S. House committee hearing Tuesday on how to rein in prescription drug prices in the U.S., what was apparent is that a consensus toward action is growing between lawmakers regardless of political party and among the policy experts who bring varying perspectives on the problem.